1. Home
  2. GNLN vs COCP Comparison

GNLN vs COCP Comparison

Compare GNLN & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlane Holdings Inc.

GNLN

Greenlane Holdings Inc.

HOLD

Current Price

$0.75

Market Cap

13.2M

ML Signal

HOLD

Logo Cocrystal Pharma Inc.

COCP

Cocrystal Pharma Inc.

HOLD

Current Price

$0.98

Market Cap

15.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNLN
COCP
Founded
2005
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Durable Goods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
15.3M
IPO Year
2019
2011

Fundamental Metrics

Financial Performance
Metric
GNLN
COCP
Price
$0.75
$0.98
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
231.6K
59.8K
Earning Date
02-22-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
8.02
EPS
N/A
N/A
Revenue
$13,275,000.00
$12,712,091.00
Revenue This Year
$1,541.21
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.01
$0.86
52 Week High
$7.73
$2.19

Technical Indicators

Market Signals
Indicator
GNLN
COCP
Relative Strength Index (RSI) 16.87 47.76
Support Level $0.77 $0.90
Resistance Level $0.91 $0.98
Average True Range (ATR) 0.14 0.07
MACD -0.01 0.00
Stochastic Oscillator 8.28 55.62

Price Performance

Historical Comparison
GNLN
COCP

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

Share on Social Networks: